StemCells Shelf Filing Seems Almost ‘Re-IPO’ (STEM)
StemCells Inc. (NASDAQ: STEM) has filed a mixed securities shelf registration that will allow the company to raise up to $100 million in securities sales via any combination of stock, debt, preferred stock, and warrants. Interestingly enough, its market cap…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
StemCells Inc. (NASDAQ: STEM) has filed a mixed securities shelf registration that will allow the company to raise up to $100 million in securities sales via any combination of stock, debt, preferred stock, and warrants.
Interestingly enough, its market cap is a mere $99.4 million as of today’s close, so we could almost try to convince you this is a re-IPO equivalent. Also, no underwriters were named.
Net proceeds from securities sold are earmarked for general corporate purposes such as working capital, capital expenditures, R&D, clinical trial expenditures, acquisitions of new technologies or businesses, and investments.
Shares closed down 3% at $1.23 in regular trading, and shares are down 10% at $1.10 in initial after-hours trading today.
Jon C. Ogg
June 24, 2008
Contact [email protected] for any questions or corrections.
